The British Journal of Psychiatry 145: 39-44 (1984)
© 1984 The Royal College of Psychiatrists
Psychophysiological changes during pharmacological treatment of patients with obsessive compulsive disorder
TP Zahn, TR Insel and DL Murphy
Twelve patients with obsessive compulsive disorder were studied with
psychophysiological measures during a randomised, double-blind placebo-
controlled drug trial. Significant clinical improvement followed six weeks
of treatment with the tricyclic antidepressant clomipramine, but was not
evident after an equal period of treatment with the monoamine oxidase
inhibitor (MAOI) clorgyline. Compared to placebo, both drugs reduced skin
conductance indices of baseline arousal, but only clomipramine reduced skin
conductance and heart rate responses to loud tones and tonic and phasic
skin conductance responses in a two-flash discrimination task. This
suggests that reductions in autonomic responses to important and/or
aversive stimuli may be critical to clinical improvement in obsessive
compulsive disorder.